Texas Recovers Nearly $34 Million From AstraZeneca In Medicaid Kickback Settlement

Texas will recover nearly $34 million from AstraZeneca Pharmaceuticals LP under a settlement resolving allegations that the drugmaker used an illegal kickback scheme to influence prescriptions covered by the state’s Medicaid program. The settlement requires AstraZeneca to pay $33,998,000 to resolve claims brought under the Texas Health Care Program Fraud Prevention Act, according to the […]

The post Texas Recovers Nearly $34 Million From AstraZeneca In Medicaid Kickback Settlement appeared first on Dallas Express.